SlideShare a Scribd company logo
1 of 23
1
ANTI-HYPERTENSIVE AGENTS:
Vasodilators
PHCL-L3-Cardiopharm-lecture09
Learning Objectives
– Classify vasodilators
– Describe the hemodynamic effects of VD
– List the adverse effects and
contraindication
– List the therapeutic uses
Classification of Vasodilators
(according to mechanism and Site of Action)
Classification based on MOA
• Directly acting Vasodilators
– Act directly on Vascular
smooth muscles
• Organic nitrates
• Drugs acting on K channels
• Calcium Channel Blockers,
• Indirectly acting
Vasodilators
– Inhibit action of
endogenous constrictors
• Those that inhibit sympathetically
mediated vasocontriction
• Those that inhibit renin-
angistensin system
General Classification
– Ca channel blockers: Inhibit
movement of Ca through L-type
channels (ie. Verapamil)
– Open K-channels: Minoxidil
(Rogaine), Diazoxide (acute HT)
– Direct vasodilator: mainly
arterioles, Hydralazine, may
inhibit calcium release
– Coupled to NO/cGMP: dilate veins
also, sodium nitroprusside,
nitroglycerin, nitrates etc
– Dopamine agonist: Fenoldopam
(Dopamine-1A subtype) for acute
hypertension
– Alpha-antagonists: Prazosin
(alpha1-), phenoxybenzamine
(irreversible)
3
Venous
Nitrates
Mixed
Calcium Antagonists
a-adrenergic Blockers
ACEI
Nitroprusside
Arterial
Minoxidil
Hydralazine
Venous
Vasodilator
Arterial
Vasodilator
Classification of Vasodilators
5
Effects of Vasodilators
• Vasodilators act:
– To increase total tissue blood flow
– To reduce arterial pressure
– To reduce central venous pressure
• Net effect:
– Reduction of cardiac preload (reduced
filling pressure) and after-load (reduced
vascular resistance), hence reduction in
cardiac work.
6
• Uses:
– Angina pectoris
• (Ca antagonists,organic nitrates)
– Cardiac failure
• (ACE inhibitors, organic nitrates)
– Hypertension
• (α-antagonists)
– Hypertensive crisis
• (nitroprusside, hydralazine, diazoxide)
Vasodilators
7
Peripheral
Vasodilators
Ca2+ - channel blockers
Dihydropiridines
Verapamil
Diltiazem
Ca2+
NO
Activators of NO/guanylate cyclase pathway
Hydralazine ?
Nitroprusside
Nitroglycerin
K+ - channels activators
Minoxidile
Diazoxide
a1 – Adrenoreceptor
antagonists
Prazosin
K+
Ang II receptor
antagonists
Losartan
VSMCs
Nitric Oxide
– Discovered in the early 1980’s.
– A molecule that acts as a hormone by
being formed in response to a signal,
causing the smooth muscles
surrounding blood vessels to relax.
– Causes blood pressure to go down
– Mechanism of action not completely
understood
NO Synthesis in Body
– Nitric oxide is formed by the oxidation of l-arginine
via an enzyme called nitric oxide synthase (NOS).
– The NOS enzyme uses NADPH and oxygen as
cosubstrates
• The NOS enzyme catalyzes a five-electron oxidation of Arginine
to NO and L-citrullline using NADH as the source of electrons.
• NOS produces NO in response to increased calcium ion
concentrations.
11
Mechanism of action and pharmacologic
effects of Organic Nitrates
• Mechanism of Action:
– Relax smooth muscles by intracellular
conversion of nitrates to Nitric Oxide (NO)
– NO activates guanylate cyclase and increases
the cells’ cyclic GMP
– Elevated cGMP dephosphorylate myosin light
chain, resulting in vascular smooth muscle
relaxation
• Pharmacologic effects:
– Relieving coronary vasospasm
– redistributing myocardial blood flow to
ischaemic areas of the myocardium
– Tolerance can develop rapidly to the effects of
nitrate therapy
13
Common Adverse Drug Reactions of
organic nitrates
• Headache
– Increase dose slowly
• Hypotension
– GLYCERYL TRINITRATE causes syncope
14
Peripheral Vasodilators
 Vasodilators (for use in Hypertension)
Hydralazine
Minoxidil
Sodium Nitroprusside
Diazoxide
***
 Vasodilators (for use in Angina)
 GLYCERYL TRINITRATE (GTN),
 ISOSORBIDE MONONITRATE
 ISOSORBIDE DINITRATE
Sodium nitroprusside
• Sodium nitroprusside
– short-acting agent (few minutes) 
administrated by infusion in
hypertensive emergencies
• (hypertensive encephalopathy, shock,
cardiac dysfunction) for max 24 hours (risk
of cumulation of cyanide  toxicity)
– Releases NO
– the stock solution should be diluted
and covered with foil to prevent
photodeactivation
– adverse effects:
• too rapid reduction of BP, nausea,
palpitation, dizziness
• cyanide metabolite (thiocynanate)
accumulation – tachycardia,
hyperventilation, arrhythmias, acidosis
CN CN
CN CN
Fe
NO
CN
- -
-
-
++
-
+
Hemodynamic profile
17
Hydralazine:
 rapidly and fairly absorbed after oral administration
 useful for hypertensive crisis during pregnancy
 Adverse effects:
 Na+ and water retention,
 systemic lupus erythematosus –
Minoxidil:
 ”Last choice” for treatment of hypertension: therapy of severe
hypertension resistant to other drugs
 prodrug its metabolite (minoxidil sulfate) is a potassium
channel opener ( repolarization + relaxation of vascular
smooth muscle)
• more effect on arterioles than on veins
• orally active
 Adverse effects:
 Na+ and water retention → coadministration with beta-vlocker and diuretic is
mandatory for this drug,
 oedemas, hypertrichosis, breast tenderness, Headache, sweating
 Topical minoxidil (Rogaine) used for correction of baldness.
Peripheral Vasodilators for
Hypertension….
18
Nitrovasodilators for Angina
– GLYCERYL TRINITRATE
• (GTN or nitoglyceryl)
• Prodrug, must be denitrated to produce
active NO
• GTN is broken down into 1,2-glyceryl
dinitrate + Free NO
• Sublingual (To avoid first pass metabolism ),
buccal, transdermal
– ISOSORBIDE MONONITRATE
• Sustained release formulation, tablets
– ISOSORBIDE DINITRATE
(RISORDAN)
• Sustained release formulation, tablets
19
Specific Uses of Nitrates
• GLYCERYL TRINITRATE (Nitriderm)
– Used for the rapid treatment of angina pain.
– To avoid first pass metabolism is given by
the sublingual route.
– May be used frequently and prophylactically
• Oral Nitrates
– Commonly given as a once a day sustained
release formulation
– Used for prophylaxis
20
Vasodilators: K channels activators
• Cause vasodilation by activating K
channels
– Eg: Diazoxide
• given by rapid iv. injection (less than 30 seconds)* in
hypertensive emergencies
• -it is a potassium channel opener
• Adv effects:
– glucose intolerance  due to reduced insulin secretion (used in
patients with inoperable insulinoma)
– Na+ and water retention, hyperglycaemia, hirsutism
• used for treating hypertensive emergencies
• but diazoxide may rarely be used if accurate infusion pumps
are not available and/or close monitoring of blood pressure is
not available
Why do we have to combine vasodilators with b-blockers and diuretics?
Summary
22
10-Vasodilators.ppt

More Related Content

What's hot

Antihypertensives drugs
Antihypertensives drugsAntihypertensives drugs
Antihypertensives drugs
Nikhil Bansal
 
Anti platelet agents
Anti platelet agentsAnti platelet agents
Anti platelet agents
Doc Pradeep
 

What's hot (20)

Vasodilators
VasodilatorsVasodilators
Vasodilators
 
Antianginal Drugs
Antianginal DrugsAntianginal Drugs
Antianginal Drugs
 
Pharmacology of Antiarrhythmic drugs
Pharmacology of Antiarrhythmic drugsPharmacology of Antiarrhythmic drugs
Pharmacology of Antiarrhythmic drugs
 
Antihypertensives drugs
Antihypertensives drugsAntihypertensives drugs
Antihypertensives drugs
 
vasodilator and vasoconstrictor.pptx
vasodilator and vasoconstrictor.pptxvasodilator and vasoconstrictor.pptx
vasodilator and vasoconstrictor.pptx
 
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Antiarrhythmic drugs bds
Antiarrhythmic drugs bdsAntiarrhythmic drugs bds
Antiarrhythmic drugs bds
 
Clonidine
ClonidineClonidine
Clonidine
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Antianginal drugs satya
Antianginal drugs satya Antianginal drugs satya
Antianginal drugs satya
 
Calcium channel blockers
Calcium channel blockersCalcium channel blockers
Calcium channel blockers
 
Anti platelet agents
Anti platelet agentsAnti platelet agents
Anti platelet agents
 
Sympathomimetics
SympathomimeticsSympathomimetics
Sympathomimetics
 
Calcium Channel Blockers
Calcium Channel Blockers Calcium Channel Blockers
Calcium Channel Blockers
 
Antihypertensive mbbs copy
Antihypertensive mbbs   copyAntihypertensive mbbs   copy
Antihypertensive mbbs copy
 
thiazides
 thiazides  thiazides
thiazides
 
Digitalis nikku ppt
Digitalis nikku pptDigitalis nikku ppt
Digitalis nikku ppt
 
Antihypertensives - drdhriti
Antihypertensives - drdhritiAntihypertensives - drdhriti
Antihypertensives - drdhriti
 

Similar to 10-Vasodilators.ppt

Hypertension.ppt
Hypertension.pptHypertension.ppt
Hypertension.ppt
Imtiyaz60
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
Imtiyaz60
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
Imtiyaz60
 

Similar to 10-Vasodilators.ppt (20)

Vasodilators
VasodilatorsVasodilators
Vasodilators
 
antihypertensive drugs.ppt
antihypertensive drugs.pptantihypertensive drugs.ppt
antihypertensive drugs.ppt
 
antihypertensive drugs
antihypertensive drugsantihypertensive drugs
antihypertensive drugs
 
C) hypertension
C) hypertensionC) hypertension
C) hypertension
 
Hypertension.ppt شه شی دی
Hypertension.ppt شه شی دی Hypertension.ppt شه شی دی
Hypertension.ppt شه شی دی
 
Hypertension.ppt
Hypertension.pptHypertension.ppt
Hypertension.ppt
 
Hypertension.ppt
Hypertension.pptHypertension.ppt
Hypertension.ppt
 
Hypertension.ppt
Hypertension.pptHypertension.ppt
Hypertension.ppt
 
Hypertension (5).ppt
Hypertension (5).pptHypertension (5).ppt
Hypertension (5).ppt
 
Hypertension.ppt
Hypertension.pptHypertension.ppt
Hypertension.ppt
 
PH1.28 Angina pectoris MANI.ppt
PH1.28 Angina pectoris MANI.pptPH1.28 Angina pectoris MANI.ppt
PH1.28 Angina pectoris MANI.ppt
 
Antianginal drugs unit-II by Dr. Monika Singh as per PCI syllabus 2020
Antianginal drugs unit-II by Dr. Monika Singh as per PCI syllabus 2020Antianginal drugs unit-II by Dr. Monika Singh as per PCI syllabus 2020
Antianginal drugs unit-II by Dr. Monika Singh as per PCI syllabus 2020
 
Directly acting Arteriolar Dilators
Directly acting Arteriolar DilatorsDirectly acting Arteriolar Dilators
Directly acting Arteriolar Dilators
 
Anti hypertensive drugs- Unit I
Anti hypertensive drugs- Unit IAnti hypertensive drugs- Unit I
Anti hypertensive drugs- Unit I
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
 

Recently uploaded

Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
ssuserdda66b
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 

Recently uploaded (20)

FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 

10-Vasodilators.ppt

  • 2. Learning Objectives – Classify vasodilators – Describe the hemodynamic effects of VD – List the adverse effects and contraindication – List the therapeutic uses
  • 3. Classification of Vasodilators (according to mechanism and Site of Action) Classification based on MOA • Directly acting Vasodilators – Act directly on Vascular smooth muscles • Organic nitrates • Drugs acting on K channels • Calcium Channel Blockers, • Indirectly acting Vasodilators – Inhibit action of endogenous constrictors • Those that inhibit sympathetically mediated vasocontriction • Those that inhibit renin- angistensin system General Classification – Ca channel blockers: Inhibit movement of Ca through L-type channels (ie. Verapamil) – Open K-channels: Minoxidil (Rogaine), Diazoxide (acute HT) – Direct vasodilator: mainly arterioles, Hydralazine, may inhibit calcium release – Coupled to NO/cGMP: dilate veins also, sodium nitroprusside, nitroglycerin, nitrates etc – Dopamine agonist: Fenoldopam (Dopamine-1A subtype) for acute hypertension – Alpha-antagonists: Prazosin (alpha1-), phenoxybenzamine (irreversible) 3
  • 5. 5 Effects of Vasodilators • Vasodilators act: – To increase total tissue blood flow – To reduce arterial pressure – To reduce central venous pressure • Net effect: – Reduction of cardiac preload (reduced filling pressure) and after-load (reduced vascular resistance), hence reduction in cardiac work.
  • 6. 6 • Uses: – Angina pectoris • (Ca antagonists,organic nitrates) – Cardiac failure • (ACE inhibitors, organic nitrates) – Hypertension • (α-antagonists) – Hypertensive crisis • (nitroprusside, hydralazine, diazoxide) Vasodilators
  • 7. 7 Peripheral Vasodilators Ca2+ - channel blockers Dihydropiridines Verapamil Diltiazem Ca2+ NO Activators of NO/guanylate cyclase pathway Hydralazine ? Nitroprusside Nitroglycerin K+ - channels activators Minoxidile Diazoxide a1 – Adrenoreceptor antagonists Prazosin K+ Ang II receptor antagonists Losartan VSMCs
  • 8. Nitric Oxide – Discovered in the early 1980’s. – A molecule that acts as a hormone by being formed in response to a signal, causing the smooth muscles surrounding blood vessels to relax. – Causes blood pressure to go down – Mechanism of action not completely understood
  • 9.
  • 10. NO Synthesis in Body – Nitric oxide is formed by the oxidation of l-arginine via an enzyme called nitric oxide synthase (NOS). – The NOS enzyme uses NADPH and oxygen as cosubstrates • The NOS enzyme catalyzes a five-electron oxidation of Arginine to NO and L-citrullline using NADH as the source of electrons. • NOS produces NO in response to increased calcium ion concentrations.
  • 11. 11 Mechanism of action and pharmacologic effects of Organic Nitrates • Mechanism of Action: – Relax smooth muscles by intracellular conversion of nitrates to Nitric Oxide (NO) – NO activates guanylate cyclase and increases the cells’ cyclic GMP – Elevated cGMP dephosphorylate myosin light chain, resulting in vascular smooth muscle relaxation • Pharmacologic effects: – Relieving coronary vasospasm – redistributing myocardial blood flow to ischaemic areas of the myocardium – Tolerance can develop rapidly to the effects of nitrate therapy
  • 12.
  • 13. 13 Common Adverse Drug Reactions of organic nitrates • Headache – Increase dose slowly • Hypotension – GLYCERYL TRINITRATE causes syncope
  • 14. 14 Peripheral Vasodilators  Vasodilators (for use in Hypertension) Hydralazine Minoxidil Sodium Nitroprusside Diazoxide ***  Vasodilators (for use in Angina)  GLYCERYL TRINITRATE (GTN),  ISOSORBIDE MONONITRATE  ISOSORBIDE DINITRATE
  • 15. Sodium nitroprusside • Sodium nitroprusside – short-acting agent (few minutes)  administrated by infusion in hypertensive emergencies • (hypertensive encephalopathy, shock, cardiac dysfunction) for max 24 hours (risk of cumulation of cyanide  toxicity) – Releases NO – the stock solution should be diluted and covered with foil to prevent photodeactivation – adverse effects: • too rapid reduction of BP, nausea, palpitation, dizziness • cyanide metabolite (thiocynanate) accumulation – tachycardia, hyperventilation, arrhythmias, acidosis CN CN CN CN Fe NO CN - - - - ++ - +
  • 17. 17 Hydralazine:  rapidly and fairly absorbed after oral administration  useful for hypertensive crisis during pregnancy  Adverse effects:  Na+ and water retention,  systemic lupus erythematosus – Minoxidil:  ”Last choice” for treatment of hypertension: therapy of severe hypertension resistant to other drugs  prodrug its metabolite (minoxidil sulfate) is a potassium channel opener ( repolarization + relaxation of vascular smooth muscle) • more effect on arterioles than on veins • orally active  Adverse effects:  Na+ and water retention → coadministration with beta-vlocker and diuretic is mandatory for this drug,  oedemas, hypertrichosis, breast tenderness, Headache, sweating  Topical minoxidil (Rogaine) used for correction of baldness. Peripheral Vasodilators for Hypertension….
  • 18. 18 Nitrovasodilators for Angina – GLYCERYL TRINITRATE • (GTN or nitoglyceryl) • Prodrug, must be denitrated to produce active NO • GTN is broken down into 1,2-glyceryl dinitrate + Free NO • Sublingual (To avoid first pass metabolism ), buccal, transdermal – ISOSORBIDE MONONITRATE • Sustained release formulation, tablets – ISOSORBIDE DINITRATE (RISORDAN) • Sustained release formulation, tablets
  • 19. 19 Specific Uses of Nitrates • GLYCERYL TRINITRATE (Nitriderm) – Used for the rapid treatment of angina pain. – To avoid first pass metabolism is given by the sublingual route. – May be used frequently and prophylactically • Oral Nitrates – Commonly given as a once a day sustained release formulation – Used for prophylaxis
  • 20. 20 Vasodilators: K channels activators • Cause vasodilation by activating K channels – Eg: Diazoxide • given by rapid iv. injection (less than 30 seconds)* in hypertensive emergencies • -it is a potassium channel opener • Adv effects: – glucose intolerance  due to reduced insulin secretion (used in patients with inoperable insulinoma) – Na+ and water retention, hyperglycaemia, hirsutism • used for treating hypertensive emergencies • but diazoxide may rarely be used if accurate infusion pumps are not available and/or close monitoring of blood pressure is not available
  • 21. Why do we have to combine vasodilators with b-blockers and diuretics?